HRSA will award up to $1 million to a single organization to update the Women's Preventive Services Guidelines through the new WISH program.
Soma Mandal, MD, MSCP, says removing MHT boxed warnings is overdue but calls for transparency on the FDA's product-specific ...
CMS' proposed G-codes, which experts stated would cause confusion in combination with the AMA's proposed codes, were not ...
Swanson, PhD, on a pilot in which integrative group medical visits improved menopause symptoms, knowledge, and self-efficacy.
The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.
Chrisandra L. Shufelt, MD, MS, FACP, MSCP, professor and chair of the Division of General Internal Medicine and associate ...
Nearly half of menopausal sleep disruption tracks with nighttime hot flashes, while the remainder appears independent, making ...
Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess ...
Sleep disturbance is often the most bothersome symptom of the menopause transition, yet it frequently goes unreported unless ...
Night sweats in a midlife patient who also reports hot flashes usually reflect menopause, but late recurrence after stopping ...
Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal ...
A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results